Physician profile
Aman Patel
NPI 1316684301
$7,523.04
in general payments reported to CMS, 2019-2025
13 companies · $2,024 in 2025
The $2,024 reported for 2025 was more than what 94% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $230 · 2023: $656 · 2024: $4,613 · 2025: $2,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,160 · Food and Beverage: $3,133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,160.33 |
| Food and Beverage | $3,132.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,949.19 | 2022-2025 | Prostep, Prostep Mica, Hoffmann |
| Orthofix Medical, INC. | $2,191.04 | 2024-2025 | Truelok |
| Linvatec Corporation | $715.76 | 2023-2024 | Colink 2, Biobrace 23mm |
| Paragon 28, INC. | $529.90 | 2024 | Ttc Nail, Activcore Nail |
| Organogenesis INC. | $341.23 | 2024-2025 | Nushield, Affinity, Puraply Wound Matrix |
| Titan Surgical Group, LLC | $207.11 | 2023-2025 | |
| Acumed LLC | $147.55 | 2025 | Acumed |
| Kerecis Limited | $129.37 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Depuy Synthes Sales INC. | $113.21 | 2024 | Hammerlock, Unium |
| Integra Lifesciences Corporation | $86.16 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $75.61 | 2024 | Restrata Wound Matrix |
| Mimedx Group, INC. | $28.85 | 2024 | |
| Lifenet Health | $8.06 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aman Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.